Sfoglia per AUTORE
CAUCHI C
Collezione AO Cuneo

  

Items : 3

International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2022 Jan;33(1):57-66. doi: 10.1016/j.annonc.2021.09.017. Epub 2021 Oct 5.
2022
AO Cuneo
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Scagliotti GV; Manegold C; Monica V; Porcu L; Wiest G; Irtelli L; Dickgreber NJ; Caffo O; Pedrazzoli P; Bearz A; Griesinger F; Follador A; Folprecht G; Schmid-Bindert G; Reck M; Chiari R; Gregorc V; Santo A; Morabito A; Schena M; Valmadre G; Borra G; Kropf-Sanchen C; Ceribelli A; Stoelben E; Cauchi C; Colantonio I; Geissler M; Meyer A; et alii...

2022
AO Cuneo
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Porcu L; Manegold C; Scagliotti GV; Monica V; Wiest G; Irtelli L; Bearz A; Caffo O; Dickgreber NJ; Follador A; Pedrazzoli P; Griesinger F; Folprecht G; Reck M; Schmid-Bindert G; Santo A; Gregorc V; Chiari R; Morabito A; Borra G; Schena M; Kropf-Sanchen C; Valmadre G; Ceribelli A; Colantonio I; Cauchi C; Stoelben E; Ladage D; Geissler M; et alii...

Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues. in Gastroenterology / Gastroenterology. 2018 Aug;155(2):479-489.e7. doi: 10.1053/j.gastro.2018.04.010. Epub 2018 Apr 13.
2018
AO Cuneo
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Mazzaferro V; Buzzoni R; Delle Fave G; Giacomelli L; Milione M; Lo Russo G; Concas L; Femia D; Prinzi N; Garattini SK; Bajetta E; Tafuto S; Di Costanzo F; Torniai M; Zaniboni A; Ortolani S; Puliafito I; Panzuto F; Colao A; Brighi N; La Salvia A; Cavalcoli F; Bongiovanni A; Fazio N; Ricci S; Duro M; Davì MV; Cauchi C; Carnaghi C; et alii...